Tucker is adept at helping Life Sciences companies navigate the complex US healthcare ecosystem, with a focus on gaining payer and provider support for treatment adoption. He develops tailored approaches that build meaningful connections with diverse stakeholder groups, including patient advocacy groups, hospital systems, and technology innovators. Accomplishing this often involves developing innovative approaches to leverage Real-World Evidence (RWE) to improve understanding of complex diseases, shift treatment paradigms, and enhance patient outcomes.

Developed digital infrastructure roadmap for a patient registry, incorporating HEOR analysis for commercial patients; aimed to capture 100k patients, enable digital clinical trials, and enhance market access 

• Uncovered technology interventions to improve treatment decisions and patient outcomes through mapping oncology ecosystem stakeholder influence; prioritized 30+ potential partnerships with >10:1 ROI

• Delivered recommendations on critical steps and key decisions related to strategy for building a consortium of strategic partners from across the healthcare ecosystem, including healthcare providers, NGOs, HealthTech, and biotech

• Designed comprehensive IDN Market Access strategy for emerging global biotech by establishing partnership strategy with >30 senior clients; efforts prioritized approaches for cross-portfolio organic growth

• Created strategy for diagnostics company to build consortium of oncology ecosystem (hospital systems, academic researchers, and patient advocacy groups), transforming testing paradigms and driving commercial success

• Co-led COVID Testing Coordination Center to scale national testing 10x by convening 40+ partner organizations (diagnostics, hospitals, labs, gov’t agencies, NGOs, employers) to aggregate and share insights